Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

被引：0

作者：

Yu, Guangbo ^{[1
]}

Zhang, Zigeng ^{[2
]}

Eresen, Aydin ^{[2
,3
]}

Hou, Qiaoming ^{[2
]}

Amirrad, Farideh ^{[4
]}

Webster, Sha ^{[4
]}

Nauli, Surya ^{[4
,5
]}

Yaghmai, Vahid ^{[2
,3
]}

Zhang, Zhuoli ^{[1
,2
,3
,6
]}

机构：

[1] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92617 USA

[2] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92868 USA

[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92612 USA

[4] Chapman Univ, Harry & Diane Rinker Hlth Sci Campus, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA

[5] Univ Calif Irvine, Dept Med, Irvine, CA 92868 USA

[6] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92617 USA

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 22期

基金：

美国国家卫生研究院;

关键词：

PDAC; immunotherapy; immune checkpoint inhibitors; radiomics; artificial intelligence; deep learning; machine learning; PD-1; BLOCKADE; ANTI-CTLA-4; IMMUNOTHERAPY; PD-1/PD-L1; GUIDELINES; CRITERIA; LIGANDS; TUMORS; TRIAL;

D O I：

10.3390/ijms252212038

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options. This review examines the challenges and potential of using immunotherapy to treat pancreatic cancer, highlighting the role of artificial intelligence (AI) as a promising tool to enhance early detection and monitor the effectiveness of these therapies. By synthesizing recent advancements and identifying gaps in the current research, this review aims to provide a comprehensive overview of how AI and immunotherapy can be integrated to develop more personalized and effective treatment strategies. The insights from this review may guide future research efforts and contribute to improving patient outcomes in pancreatic cancer management.

引用

页数：14

共 50 条

[21] Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings
Wang, Gary X.
Kurra, Vikram
Gainor, Justin F.
Sullivan, Ryan J.
Flaherty, Keith T.
Lee, Susanna I.
Fintelmann, Florian J.
RADIOGRAPHICS, 2017, 37 (07) : 2132 - 2144
[22] The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
Chengdi Wang
Jingwei Li
Qiran Zhang
Jiayang Wu
Yuxuan Xiao
Lujia Song
Hanlin Gong
Yalun Li
BMC Cancer, 21
[23] Combinatorial immune checkpoint inhibitor therapy in anaplastic thyroid cancer
Chakraborty, Sanjukta
Maniyar, Rachana R.
Dadafarin, Sina
Ben Rahoma, Ghada
Singh, Sarnath
Moscatello, Augustine
Geliebter, Jan
Tiwari, Raj K.
CANCER RESEARCH, 2019, 79 (13)
[24] ENDOCRINE EMERGENCIES IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR LUNG CANCER
Fowler, Cosmo
Nangia, Vaibhuv
Goldberg, Daniel
Chism, Lauren
Pastores, Stephen
CRITICAL CARE MEDICINE, 2024, 52
[25] Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer
Huang, Xuan-zhang
Gao, Peng
Wang, Zhen-ning
JAMA ONCOLOGY, 2020, 6 (04) : 586 - 587
[26] Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)
Jakubowski, Christopher D.
Azad, Nilofer S.
CHINESE CLINICAL ONCOLOGY, 2020, 9 (01)
[27] Artificial intelligence in pancreatic cancer
Huang, Bowen
Huang, Haoran
Zhang, Shuting
Zhang, Dingyue
Shi, Qingya
Liu, Jianzhou
Guo, Junchao
THERANOSTICS, 2022, 12 (16): : 6931 - 6954
[28] Therapeutic potential of MET inhibitor combined with immune checkpoint blockade in pancreatic cancer
Gao, Mei
Lin, Miranda
Yang, Yachao
Kim, Joseph
CANCER RESEARCH, 2019, 79 (13)
[29] Intratumoral heterogeneity and immune checkpoint inhibitor response in the KPC pancreatic cancer model
Roth, Sarah Martinez
CANCER RESEARCH, 2019, 79 (13)
[30] Monitoring of thyroid function tests in patients receiving immune checkpoint inhibitor therapy
Slattery, Timothy
Sacks, Lori
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 24 - 24

← 1 2 3 4 5 →